Thursday, July 31st, 2025

Suntec REIT: Resilient Performance Amidst Market Challenges

Date of Report: October 25, 2024
Broker: CGS International Securities


Financial Performance and Key Metrics

  • 3Q24 Financial Results: Suntec REIT reported a 4.6% year-on-year decline in gross revenue, down to S$117.7 million, and a 5.7% decrease in net property income (NPI) to S$79.8 million. The decline was mainly due to reduced contributions from Suntec Convention, 55 Currie St, and The Minster Building. However, strong performance at Suntec Office and Suntec Mall helped offset some losses.
  • Distribution Per Unit (DPU): DPU for 3Q24 was 1.58 Singapore cents, aligning with 25.5% of the FY24 forecast.
  • Debt and Leverage: Aggregate leverage stood at 42.3% as of 3Q24. The all-in debt cost averaged 4.06% during this quarter, with an expectation to rise to 4.2% for the full year.

Singapore Portfolio Highlights

  • Office Space Performance: Suntec REIT’s Singapore office portfolio demonstrated robust occupancy at 99.1% as of end-3Q24. Notably, the portfolio benefitted from a 12.9% rental reversion in 3Q24, with Suntec Office alone achieving a 14% rental reversion on 132,000 square feet of leased space.
  • Future Rent Reversion: The trust has guided for continued positive rent reversions, with leases expiring in 4Q24/FY25 averaging S$9.59/S$10.05 per square foot.

Retail Performance at Suntec Mall

  • Occupancy and Tenant Sales: Suntec Mall maintained a high occupancy rate of 98.4% as of end-3Q24. Although shopper traffic increased by 6% year-on-year, tenant sales showed a slight decline of 1%.
  • Rental Reversion and Growth: The mall achieved a robust 21.4% rental reversion in 3Q24. The management expects this positive trend to continue, driven by a favorable tourism outlook and increased events.
  • Suntec Convention: Revenue from Suntec Convention grew by 16.5% year-on-year in 1H24, supported by a rise in meetings, incentives, conferences, and exhibitions (MICE) events.

International Portfolio

  • Australian Portfolio: Committed office occupancy in Australia reached 90.6% by 3Q24, an increase from previous quarters. Occupancy at 55 Currie St rose to 61.4%. However, the management noted challenging leasing conditions in Melbourne and Adelaide due to high vacancy rates and increased tenant incentives.
  • London Portfolio: The Minster Building in London had 8.7% of its space vacant as of 3Q24, but Suntec REIT aims to fully lease this space by the end of 2024, with the backfilling expected to contribute positively from FY25 onwards.

Capital Recycling and Divestment Strategy

  • Divestments in Singapore: Suntec REIT successfully divested approximately 50% of its targeted S$100 million worth of strata units at Suntec Office.
  • Future Sales Plans: In the medium term, the REIT aims to divest mature assets in Australia, with transactions expected as market activity picks up.

ESG Commitment

  • ESG Scores and Goals: Suntec REIT achieved a combined ESG score of C+ for FY23, with environmental, social, and governance pillars rated B-, C, and C, respectively. The REIT scored an A+ for ESG controversies.
  • Environmental Goals: The REIT targets carbon neutrality for all assets in Australia and the UK by 2030 and full portfolio net-zero carbon status by 2050. Currently, 70% of its debt is green or sustainability-linked.
  • Social and Community Initiatives: Initiatives included a toy collection drive benefiting 2,000 underprivileged children and a donation drive at Suntec City supporting educational initiatives.

Outlook and Rating

  • Broker Recommendations: CGS International Securities has reiterated its Hold rating on Suntec REIT, with a target price of S$1.38. The potential downside risk stems from the valuation of its Australian office portfolio and potential higher leverage. However, faster-than-anticipated balance sheet strengthening through asset recycling could be an upside.

  • Dividend Yield and Price Performance: Suntec REIT’s dividend yield for FY24 is projected at 5.0%, with potential increases to 5.7% by FY26. Its price target offers a 10.4% upside from the current price, as noted in the report.

Biotech Sector Rebounds: FDA Approvals Surge and Amgen (AMGN) Shows Promise in 2024

Intermediate Term Market Outlook: December 2024 Intermediate Term Market Outlook: December 2024 Broker Name: Argus Research Co. Date of Report: Tuesday, December 10, 2024 Market Overview The market outlook for the intermediate term remains...

BOC Positioned for Growth Amid China’s Strategic Policy Boost Following Politburo Meeting

Date of Report: September 26, 2024Broker: CGS International Securities BOC Overview Bank of China (BOC) is highlighted as one of the top picks within the banking sector by analysts in the September 2024 report....

Trump Victory Sparks Market Rally: Key Stocks to Watch in Malaysia

Malaysia Retail Research – Comprehensive Analysis of Key Companies Malaysia Retail Research – Comprehensive Analysis of Key Companies Date: November 7, 2024 Broker Name: CGS International Market Overview In the wake of Donald Trump...